Review Article
Comparative Evaluation of Recombinant Protein Production in Different Biofactories: The Green Perspective
Table 1
Highest yields of the expression of the four selected recombinant pharmaceutical proteins in “traditional” heterologous production platforms.
| Recombinant protein | Heterologous expression system | Highest expression level | Reference |
| hGAD65 | Escherichia coli | 12.5 mg/mL | [15] | Saccharomyces cerevisiae | 0.46 mg/mL | [27] | Pichia pastoris | 0.42 mg/mL | [27] | Spodoptera frugiperda cells | 0.02 mg/mL | [18] | Mouse myeloma cells | 1.67 mg/L | [16] |
| NVCP | Escherichia coli
*
| 56 mg/L | [49] | Pichia pastoris
*
| 10 mg/L | [50] | Spodoptera frugiperda cells* | 125 mg/L | [29] | Baby hamster kidney cells* | 1010 particles/mL | [51] |
| 2G12 | Hybridoma clones | 10 pg/cell/day | [60] |
| hIL-6 | Escherichia coli | 7.5 mg/mL | [102] | Pichia pastoris | 0.28 mg/mL | [104] | Spodoptera frugiperda cells | 0.001 mg/mL | [106] |
|
|
Reported values are the highest yield data of purified or partially purified recombinant protein because of the absence of expression data.
|